Product Images Lotronex

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Lotronex NDC 65483-894 by Prometheus Laboratories Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - lot00 0006 01

Chemical Structure - lot00 0006 01

Figure 1 - lot00 0006 02

Figure 1 - lot00 0006 02

Principal Display Panel - Lotronex 0.5 mg Bottle Label - lot00 0007 03

Principal Display Panel - Lotronex 0.5 mg Bottle Label - lot00 0007 03

LOTRONEX is a medication that contains alosetron hydrochloride in film-coated tablets, which require dispensing with a medication guide attached due to federal law. It should be stored in a light-resistant container at controlled room temperature. For more information on dosage and administration, see the prescribing information in the USP. The medication is manufactured by Prometheus Laboratories Inc. in Canada.*

Principal Display Panel - Lotronex 0.5 mg Carton - lot00 0007 04

Principal Display Panel - Lotronex 0.5 mg Carton - lot00 0007 04

Each film-coated tablet of NDX 03 EIRENES LUTITTNEX (also known as LOTRONEX) contains 0.5 mg alosetron hydrochloride. The medication guide is included in the box, which must be followed for dispensing it as per federal law. A pharmacist's label must be affixed to the package.*

Principal Display Panel - Lotronex 1 mg Bottle Label - lot00 0007 05

Principal Display Panel - Lotronex 1 mg Bottle Label - lot00 0007 05

LOTRONEX (alosetron hydrochloride) is a medication available in tablet form, with each film-coated tablet containing 1 mg of alosetron hydrochloride. Dispensing LOTRONEX requires the Medication Guide attached in accordance with Federal Law. The medication should be maintained in a tight, light-resistant container, and dosage and administration details are available in the prescribing information in the USP. The recommended storage temperature is 20-25°C (68-77°F). This medication is manufactured by Prometheus Laboratories Inc. in San Diego, CA and made in Canada.*

Principal Display Panel - Lotronex 1 mg Carton - lot00 0007 06

Principal Display Panel - Lotronex 1 mg Carton - lot00 0007 06

LOTRONEX is a medication that comes in the form of film-coated tablets. Each tablet contains 1 mg of alosetron hydrochloride. The medication guide is included in the box and dispensing is required under federal law.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.